IRIS
CAPURSO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.410
AS - Asia 7.409
NA - Nord America 4.709
SA - Sud America 1.479
AF - Africa 130
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.148
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.840
US - Stati Uniti d'America 4.469
SG - Singapore 2.979
CN - Cina 2.276
BR - Brasile 1.236
HK - Hong Kong 914
IT - Italia 699
VN - Vietnam 604
FR - Francia 404
SE - Svezia 368
DE - Germania 299
GB - Regno Unito 208
FI - Finlandia 121
IN - India 117
CA - Canada 116
AR - Argentina 104
BD - Bangladesh 89
NL - Olanda 88
MX - Messico 83
PL - Polonia 81
AT - Austria 80
ZA - Sudafrica 65
TR - Turchia 60
JP - Giappone 56
ES - Italia 53
IQ - Iraq 53
ID - Indonesia 44
EC - Ecuador 36
IE - Irlanda 32
PK - Pakistan 29
UZ - Uzbekistan 27
UA - Ucraina 26
LT - Lituania 24
VE - Venezuela 24
BE - Belgio 18
PY - Paraguay 18
SA - Arabia Saudita 18
CO - Colombia 16
RO - Romania 15
UY - Uruguay 14
PH - Filippine 13
CL - Cile 12
IL - Israele 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
KE - Kenya 11
NP - Nepal 11
TW - Taiwan 11
AU - Australia 9
CH - Svizzera 9
EG - Egitto 9
JO - Giordania 9
OM - Oman 9
TN - Tunisia 9
IR - Iran 8
MY - Malesia 8
PE - Perù 8
BH - Bahrain 7
JM - Giamaica 7
CR - Costa Rica 6
DZ - Algeria 6
MD - Moldavia 6
PT - Portogallo 6
TH - Thailandia 6
CZ - Repubblica Ceca 5
HN - Honduras 5
HU - Ungheria 5
LB - Libano 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GY - Guiana 4
KZ - Kazakistan 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
NI - Nicaragua 3
PA - Panama 3
SR - Suriname 3
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
GR - Grecia 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
ML - Mali 2
NG - Nigeria 2
PR - Porto Rico 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
Totale 21.127
Salva come PNG Salva come JPEG
Città #
Singapore 1.493
Moscow 1.031
Dallas 928
Hong Kong 901
Ashburn 770
San Jose 578
Shanghai 444
Hefei 349
Lauterbourg 302
Beijing 260
Ho Chi Minh City 211
New York 206
Milan 162
Hanoi 146
Los Angeles 139
São Paulo 125
Nuremberg 94
Boardman 87
Munich 87
Lawrence 85
Princeton 85
Orem 75
Rome 75
Warsaw 67
Santa Clara 65
Tokyo 51
Johannesburg 49
Montreal 49
Turku 48
Helsinki 47
Rio de Janeiro 45
Guangzhou 41
Brooklyn 40
Atlanta 39
London 39
Council Bluffs 38
Vienna 38
Chennai 37
Frankfurt am Main 37
Stockholm 36
Chicago 35
Amsterdam 34
Denver 33
Poplar 33
Dublin 31
Phoenix 30
Washington 30
Seattle 28
Belo Horizonte 26
Houston 26
Lappeenranta 26
Manchester 26
Da Nang 25
Mexico City 25
Boston 24
Brasília 24
Tashkent 24
Ankara 23
Cesano Boscone 21
Curitiba 21
Toronto 21
Barnet 20
Columbus 20
Shenzhen 20
Brescia 19
San Francisco 19
The Dalles 19
Assago 18
Majano 18
Haiphong 17
Paris 17
Porto Alegre 17
Campinas 16
Hangzhou 16
Mumbai 16
Minneapolis 15
Salvador 15
Tianjin 15
Bergamo 14
Jakarta 14
Jiaxing 14
Baghdad 13
Biên Hòa 13
Brussels 13
Dhaka 13
New Delhi 13
Goiânia 12
Pune 12
Secaucus 12
Thái Bình 12
City of London 11
Fortaleza 11
Guayaquil 11
Montevideo 11
Quito 11
Ribeirão Preto 11
Bologna 10
Bắc Ninh 10
Florence 10
Naples 10
Totale 10.523
Salva come PNG Salva come JPEG
Nome #
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 160
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 159
Asymptomatic Chronic Elevation of Serum Pancreatic Enzymes: How to Deal with It? 154
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 150
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 140
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 138
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression 131
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 131
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 129
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma 127
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 124
Genetic and non-genetic risk factors for early-onset pancreatic cancer 123
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 122
DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASOUND-FINE NEEDLE ASPIRATION (EUS-FNA) IN THE EVALUATION OF PANCREATIC NEUROENDOCRINE NEOPLASMS (PNEN) GRADING 122
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 121
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 121
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 119
The prevalence of pancreatic cystic lesions in patients with liver cirrhosis is double that in controls 117
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 117
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 116
European evidence-based guidelines on pancreatic cystic neoplasms 116
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 115
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 113
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 111
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk 110
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 110
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 110
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 110
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 106
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 105
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 105
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 104
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 103
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 103
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 102
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 102
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 101
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 99
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 99
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 98
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 98
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 97
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 96
Urgent manifestations of immunoglobulin G4-related disease 96
ENDOSCOPIC ULTRASOUND (EUS)-GUIDED RADIOFREQUENCY ABLATION (RFA) OF A SYMPTOMATIC PANCREATIC INSULINOMA 95
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 94
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer 94
ENDOSCOPIC ULTRASOUND-GUIDED HYBRID THERM ABLATION (EUS-HTP) IN PATIENTS (PTS) WITH LOCALLY ADVANCED (LA) PANCREATIC DUCTAL ADENOCARCINOMA (PDAC): A CASE-CONTROL COMPARATIVE SURVIVAL ANALYSIS 94
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 92
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 92
Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohort study 91
Activation of MNK2/eIF4E Pathway by the Splicing Factor SRSF1 Supports Pancreatic Cancer Cell Survival to Genotoxic Stress 91
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 91
Accuracy of TNM staging system in prognostic siratification of stage IV digestive endocrine tumors 89
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 89
Alcohol and gastrointestinal cancers 88
Consensus guidelines on severe acute pancreatitis 88
The EFFect of dietary fat content on the recurrence of pancreaTitis (EFFORT): Protocol of a multicenter randomized controlled trial: Protocol of the EFFORT randomized trial: dietary fat reduction and pancreatitis recurrence 87
A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH 87
The i-EUS consensus on the management of pancreatic fluid collections – Part 1 87
ACUTE PANCREATITIS PATIENT REGISTRY TO EXAMINE NOVEL THERAPIES IN CLINICAL EXPERIENCE (APPRENTICE): AN INTERNATIONAL MULTICENTER CONSORTIUM FOR THE STUDY OF ACUTE PANCREATITIS 86
Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations 86
4. Smoking, alcohol and family history of cancer as risk factors for small intestinal neuroendocrine tumors: a systematic review and meta-analysis 86
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 85
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid 85
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 85
Risk factors for the occurrence of ampullary tumors: A case-control study 84
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 84
Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study 84
EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY 83
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 83
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 83
Early onset pancreatic cancer. Risk factors, presentation and outcome 83
Addendum 82
Predicting the need for step-up after EUS-guided drainage of peripancreatic fluid collections, including Quadrant-Necrosis-Infection score validation: A prospective cohort study 82
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency 81
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 81
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 80
Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail 80
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED STAGE. IV DIGESTIVE ENDOCRINE. TUMORS 79
The impact of nutritional status on pancreatic cancer therapy 79
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 79
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer 79
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 79
Delay in Pancreatic Endoscopic Ultrasound during the COVID-19 Pandemic in a Pancreas/Tertiary Referral Center 78
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 78
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 76
Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management 76
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 76
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 76
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals 75
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 75
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 74
FEASIBILITY OF ORAL AND DUODENAL MICROBIOTA ANALYSIS OF PANCREATIC CANCER PATIENTS AND CONTROLS 74
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk 74
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer 74
ABO blood groups and pancreatic cancer risk and survival: Results from the PANcreatic Disease ReseArch (PANDoRA) consortium 74
Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms 73
Exocrine pancreatic insufficiency in diabetic patients. prevalence, mechanisms, and treatment 73
How to get away with COVID-19: endoscopy during post-peak pandemic. A perspective review 73
Totale 9.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.386
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202269 0 0 1 29 9 2 4 3 10 3 2 6
2022/2023642 196 114 47 1 10 80 78 63 30 2 12 9
2023/20241.058 48 36 81 256 70 149 46 111 18 29 65 149
2024/20254.788 512 138 88 131 300 460 557 385 880 600 349 388
2025/202615.069 1.165 1.174 986 1.939 1.208 528 1.518 1.139 4.552 860 0 0
Totale 21.711